Lung Institute to Celebrate New Expansion with Ribbon Cutting Ceremony

Scottsdale, AZ (PRWEB) February 03, 2015

On February 9th, a new stem cell treatment facility will open its doors in Scottsdale. The Lung Institute provides patients with an effective way to treat their lung diseases, such as COPD and pulmonary fibrosis. With locations in Tampa and Nashville, the Lung Institute has made positive strides in each city and will bring the same amount of involvement to the Scottsdale community.

Headed by Dr. Burton Feinerman, a world-renowned physician and expert in the field of regenerative medicine, the Lung Institute has performed hundreds of minimally invasive, outpatient stem cell therapies for a variety of debilitating lung diseases. With these treatments, the Lung Institute successfully offers world-class care to their patients who travel from around the world to visit their clinics.

The addition of this facility means more medical, sales and administrative jobs for Scottsdale residents. Since most patients travel to receive treatment, local businesses will benefit from the increase in visitors. Patient coordinators at the Lung Institute actively promote all that Scottsdale has to offer as an ancillary benefit to obtaining advanced treatment for lung disease in Scottsdale. Patient coordinators not only book the stem cell treatments, but they also coordinate hotel accommodations and arrange shuttle services to and from the airport. The patients itinerary is completely taken care of by the Lung Institute and their hotel stay and shuttle services are complimentary for all out-of-town patients.

The clinics opening will be celebrated with a ribbon cutting ceremony held at the new facility. The medical staff, Lung Institute corporate team, community representatives and members of the Scottsdale Chamber of Commerce will be present at the event.

With Scottsdale being a medical hub for new technology, there are unlimited resources in this community. Says Lynne Flaherty, Executive Vice President of the Lung Institute, Additionally, our patients will really enjoy all of the attractions the Scottsdale area has to offer.

Join us for the official ribbon cutting ceremony for the Lung Institute:

When: Monday, February 9, 2015, at 5:00 p.m. Where: Lung Institute, 8377 East Hartford Drive, Suite 120, Scottsdale, AZ 85255 About the Lung Institute At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (855)469-5864

See the original post here:
Lung Institute to Celebrate New Expansion with Ribbon Cutting Ceremony

UCLA Researchers Receive Prestigious CIRM Tools and Technologies Award

Contact Information

Available for logged-in reporters only

Newswise Two scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received a California Institute of Regenerative Medicine (CIRM) Tools and Technology Award that will forward revolutionary stem cell medicine. The UCLA researchers were among only 20 scientists nationwide to receive the Tools and Technologies Award, the most of any institution represented.

Recipients receiving awards for their respective projects included Dr. James Dunn, professor of bioengineering and surgery, for his research investigating skin-derived precursor stem cells for the treatment of enteric neuromuscular dysfunction, and Dr. Hanna Mikkola, associate professor of molecular, cell and developmental biology, for her work creating a suite of engineered human pluripotent stem cell lines to facilitate the generation of patient specific hematopoietic stem cells.

UCLA Broad Stem Cell Research Center Director Owen Witte said, We are very grateful for CIRMs support of these potentially groundbreaking projects intended to overcome significant bottlenecks in driving stem cell therapies to the clinic.

The CIRM Tools and Technologies initiative is designed specifically to support research that can address regenerative medicines unique translational challenges. The award seeks to facilitate the creation, design and testing of broadly applicable novel tools and technologies for addressing translational bottlenecks to stem cell therapies.

Dr. James Dunn: Unlocking the Secrets of Neuromuscular Dysfunction

Dr. Dunns cutting-edge work focuses on assessing the therapeutic potential of skin-derived stem cells to treat neuromuscular gastrointestinal diseases. CIRM reviewers noted that, if successfully completed, the project would likely have a major impact upon the field. His lab will develop a model of intestinal neuromuscular dysfunction that is amenable to stem cell transplantation.

Dunns novel approach to treat these patients will use stem cells reprogrammed from the patients own skin (induced pluripotent stem cells) to generate the neural system to correct the intestinal dysfunction. Dunn and his team hope the research will result in a clinical trial using patient specific induced pluripotent stem cells and provide a critical step toward an improved therapeutic approach and to treat intestinal neuromuscular dysfunction.

Dr. Dunns research was additionally supported by the National Institutes and Sun West Company.

Link:
UCLA Researchers Receive Prestigious CIRM Tools and Technologies Award

Faversham woman Roisin Kelleher first in UK to receive life-saving stem cell treatment for cystic fibrosis

Favershams pioneering patient Roisin Kelleher has become the first person in the UK to receive life-saving treatment for cystic fibrosis.

Roisin, of Whitstable Road, returned home from America after spending two weeks in the Dominican Republic undergoing stem-cell transplants.

The 20-year-old, who is a pupil at Queen Elizabeths Grammar School, was also diagnosed with pulmonary hypertension in July last year and her health suddenly and rapidly declined.

Roisin and her mum Anntoinette lying in bed, with brother Cian

Her breathlessness, fatigue and endless amounts of medication and trips to London hospitals had taken a full grip on her life and school and dreams of university became completely out of reach.

In a life-changing moment, doctors suggested that Roisin was placed on a waiting list for a double lung transplant, a suggestion that Roisin described as like signing my own death warrant.

Roisin Kelleher has cystic fibrosis and pulmonary hypertension. Picture: Tony Flashman

But her mother Anntoinette refused to give up hope and discovered Dr Grekos miraculous treatment in the Dominican Republic.

Adult stem cell treatment heals the damaged lung tissues by harvesting healthy cells from the patients bone marrow and that of a genetic relative who does not suffer from CF.

For Roisin, the donor was her mother.

See more here:
Faversham woman Roisin Kelleher first in UK to receive life-saving stem cell treatment for cystic fibrosis

Topeka Zoo Black Bear Undergoes Stem Cell Therapy

Peek the American black bear (Courtesy: Topeka Zoo)

Peek the bear is shown undergoing a CT scan at St. Francis Health Center in this photo from the Topeka Zoo.

St. Francis Health Center staff watch as a CT scan is performed on Peek the black bear. (Courtesy: Topeka Zoo)

TOPEKA, Kan. (WIBW) - An American black bear at the Topeka Zoo may be the first bear ever to undergo stem cell treatment for a spinal problem.

Zoo Director Brendan Wiley says Peek, who is 20-years old, started losing control of her hind legs two weeks ago. The condition worsened and zoo staff says pain medication was not having any impact on the situation.

One of the unique things about this scenario is that Peek hasnt acted like anything is hurting her. It is like the front half of her body can no longer communicate with the back half, said Animal Care Supervisor Shanna Simpson.

The zoo worked with St. Francis Health Center to perform a CT scan. Peek was tranquilized and transported to St. Francis' imaging facilities.

"Our first priority is human patient safety and access," says Brent Wilkins, director of Imaging Services at St. Francis Health. "We work with the Topeka Zoo to accommodate animals that need CT scans in off hours when one of our CT scanners is available. We made sure the bear was separated from any other patients and performed a high-level decontamination and cleaning of the area, called a terminal cleaning, after the bears visit."

The scan revealed an area of Peek's spine with spinal stenosis, a narrowing of her spinal column, causing pressure on the spinal cord.

In anticipation of future treatment, Dr. Larry Snyder and Dr. Travis Gratton, veterinarians from Topeka's University Small Animal Hospital were contacted. Before Peek was transported for the CT scan, the two harvested fat cells, which they converted to stem cells to inject back into her. The theory behind the treatment is that the stem cells can stimulate damaged area to repair and heal itself.

More:
Topeka Zoo Black Bear Undergoes Stem Cell Therapy

Tampa stem cell clinic is long on promises, not evidence

TAMPA Dr. Burton Feinerman has spent more than a decade using stem cell therapies that are banned in the United States, sending desperate families to Peru seeking treatments for their babies' terminal conditions like Tay-Sachs disease.

The therapies are costly and unproven, and no insurer will cover them. But there is no law against a U.S. doctor recommending them, as long as they aren't performed here.

Now the 85-year-old pediatrician is focusing on a stem cell therapy he can perform in Tampa, for seniors with such incurable lung conditions as chronic obstructive pulmonary disease, or COPD.

Feinerman, medical director of the Tampa-based Lung Institute, says lung patients tend to get the most benefit from stem cell therapies. And he can treat them in the United States because he is re-infusing patients with their own stem cells, a legal process under certain circumstances.

But it's not approved as a lung disease therapy in this country. Neither the American Lung Association nor the International Society for Stem Cell Research have endorsed it. Medicare won't cover it.

So Feinerman's patients must pay cash between $7,500 and $12,000 for a three-day treatment, plus $4,500 for additional "boosters'' of cells extracted from their blood or abdominal fat.

The Lung Institute has produced a slick website and an advertising campaign, and it puts on seminars at which prospects can hear the testimonials of satisfied patients.

But there are no clinical data showing stem cell therapies benefit patients with lung disease, said Dr. Daniel Weiss, a professor at the University of Vermont College of Medicine and a leading lung disease researcher. Further, studies of mice suggest that if the therapies work, it likely would help only acute lung conditions like respiratory distress syndrome, not chronic conditions like COPD.

"I do not recommend any type of cell therapy (for lung disease) at this point," Weiss said.

Feinerman insists the doubters are wrong. "Just go to Google," he told a Times reporter who asked him for clinical research to back his claims. Lung Institute employees later provided citations for three journal articles, but none showed the treatments worked. In fact, Weiss wrote two of the articles.

Continue reading here:
Tampa stem cell clinic is long on promises, not evidence